[1] Guía para la Atención de la Esclerosis Lateral Amiotrófica (ELA) en España 2009.
[2] Abordaje de la Esclerosis Lateral Amiotrófica. Estrategia en Enfermedades Neurodegenerativas del Sistema Nacional de Salud 2018.
[3] López-Gómez JJ, Ballesteros-Pomar MD, Torres-Torres B, De la Maza BP, Penacho-Lázaro MÁ, Palacio-Mures JM, et al. Malnutrition at diagnosis in amyotrophic lateral sclerosis (als) and its influence on survival: Using glim criteria. Clin Nutr Edinb Scotl 2020. https://doi.org/10.1016/j.clnu.2020.05.014.
DOI: 10.1016/j.clnu.2020.05.014
[4] Urbez MR. Rehabilitación Respiratoria. Guía Clínica Para El Trat. Escler. Lateral Amiotrófica. Primera, 2022, p. 105–18.
[5] Lisbona A. Soporte Nutricional. Guía Clínica Para El Trat. Escler. Lateral Amiotrófica, Signo Comunicación Consultores; 2022, p. 71–6.
[6] Rodríguez De Rivera FJ, Oreja Guevara C, Sanz Gallego I, San José Valiente B, Santiago Recuerda A, Gómez Mendieta MA, et al. Evolución de pacientes con esclerosis lateral amiotrófica atendidos en una unidad multidisciplinar. Neurología 2011;26:455–60. https://doi.org/10.1016/j.nrl.2011.01.021.
DOI: 10.1016/j.nrl.2011.01.021
[7] Lopez-Gomez JJ, Torres-Torres B, Gomez-Hoyos E, Fernandez-Buey N, Ortola-Buigues A, Castro-Lozano A, et al. Influence of a multidisciplinary protocol on nutritional status at diagnosis in amyotrophic lateral sclerosis. Nutr Burbank Los Angel Cty Calif 2018;48:67–72. https://doi.org/10.1016/j.nut.2017.11.010.
DOI: 10.1016/j.nut.2017.11.010
[8] Virgili Casas MN. La opinión del paciente cuenta: experiencia en la atención nutricional en un equipo multidisciplinar. Nutr Hosp 2015:56–66. https://doi.org/10.3305/nh.2015.31.sup5.9132.
[9] Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Mot Neuron Disord Off Publ World Fed Neurol Res Group Mot Neuron Dis 2000;1:293–9. https://doi.org/10.1080/146608200300079536.
DOI: 10.1080/146608200300079536
[10] de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 2008;119:497–503. https://doi.org/10.1016/j.clinph.2007.09.143.
DOI: 10.1016/j.clinph.2007.09.143
[11] Agencia Española de Medicamentos y Productos Sanitarios A. Ficha Técnica Riluzol 2014.
[12] Burgos R, Breton I, Cereda E, Desport JC, Dziewas R, Genton L, et al. ESPEN guideline clinical nutrition in neurology. Clin Nutr Edinb Scotl 2018;37:354–96. https://doi.org/10.1016/j.clnu.2017.09.003.
DOI: 10.1016/j.clnu.2017.09.003
[13] Del Olmo García Ma D, Virgili Casas N, Cantón Blanco A, Lozano Fuster FM, Wanden-Berghe C, Avilés V, et al. [Nutritional management of amyotrophic lateral sclerosis: summary of recommendations]. Nutr Hosp 2018;35:1243–51. https://doi.org/10.20960/nh.2162.
DOI: 10.20960/nh.2162
[14] Suárez-Escudero JC, Lema Porto KS, Palacio Patiño D, Izquierdo Moreno M, Bedoya Londoño CL. Disfagia orofaríngea neurogénica: concepto, fisiopatología, clínica y terapéutica. Arch Neurocienc 2022;27. https://doi.org/10.31157/an.v27i4.347.
DOI: 10.31157/an.v27i4.347
[15] R. Burgos BS H Segurola, A Romagosa, C Puiggrós, C Vázquez, G Cárdenas, N,. TRADUCCIÓN Y VALIDACIÓN DE LA VERSIÓN EN ESPAÑOL DE LA ESCALA EAT-10. Nutr Hosp 2012:2048–54. https://doi.org/10.3305/nh.2012.27.6.6100.
[16] Rofes L, Arreola V, Mukherjee R, Clavé P. Sensitivity and specificity of the Eating Assessment Tool and the Volume-Viscosity Swallow Test for clinical evaluation of oropharyngeal dysphagia. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 2014;26:1256–65. https://doi.org/10.1111/nmo.12382.
DOI: 10.1111/nmo.12382
[17] Duncan S, McAuley DF, Walshe M, McGaughey J, Anand R, Fallis R, et al. Interventions for oropharyngeal dysphagia in acute and critical care: a systematic review and meta-analysis. Intensive Care Med 2020;46:1326–38. https://doi.org/10.1007/s00134-020-06126-y.
DOI: 10.1007/s00134-020-06126-y
[18] Motor neurone disease: assessment and management. London: National Institute for Health and Care Excellence (NICE); 2019.
[19] Oliver D, Radunovic A, Allen A, McDermott C. The development of the UK National Institute of Health and Care Excellence evidence-based clinical guidelines on motor neurone disease. Amyotroph Lateral Scler Front Degener 2017;18:313–23. https://doi.org/10.1080/21678421.2017.1304558.
DOI: 10.1080/21678421.2017.1304558
[20] Ngo ST, Mi JD, Henderson RD, McCombe PA, Steyn FJ. Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions. Degener Neurol Neuromuscul Dis 2017;7:95–108. https://doi.org/10.2147/DNND.S120607.
DOI: 10.2147/DNND.S120607
[21] Muscaritoli M, Kushta I, Molfino A, Inghilleri M, Sabatelli M, Rossi Fanelli F. Nutritional and metabolic support in patients with amyotrophic lateral sclerosis. Nutr Burbank Los Angel Cty Calif 2012;28:959–66. https://doi.org/10.1016/j.nut.2012.01.011.
DOI: 10.1016/j.nut.2012.01.011
[22] Gorgues Zamora J. Ayudas técnicas para facilitar la alimentación de las personas discapacitadas. Offarm n.d.;28:108–13.
[23] International Dysphagia Diet Standardisation Initiative (IDDSI) n.d.
[24] White S, Zarotti N, Beever D, Bradburn M, Norman P, Coates E, et al. The nutritional management of people living with amyotrophic lateral sclerosis: A national survey of dietitians. J Hum Nutr Diet Off J Br Diet Assoc 2021;34:1064–71. https://doi.org/10.1111/jhn.12900.
DOI: 10.1111/jhn.12900
[25] Coates E, Zarotti N, Williams I, White S, Halliday V, Beever D, et al. Patient, carer and healthcare professional perspectives on increasing calorie intake in Amyotrophic Lateral Sclerosis. Chronic Illn 2023;19:368–82. https://doi.org/10.1177/17423953211069090.
DOI: 10.1177/17423953211069090
[26] Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis 2007;44:S27–72. https://doi.org/10.1086/511159.
DOI: 10.1086/511159
[27] Ley 2/2010, de 8 de abril, de derechos y garantías de la dignidad de la persona en el proceso de la muerte. n.d.
[28] Scull Torres M. La observancia de la bioética en el cuidado paliativo de enfermos con esclerosis lateral amiotrófica. Pers Bioét 2019;23:111–21. https://doi.org/10.5294/pebi.2019.23.1.7.
DOI: 10.5294/pebi.2019.23.1.7
[29] Sancho J, Candela A, Gómez E, León M, Doménech R, Ferreras J, et al. Guía para el manejo de los problemas respiratorios de la ELA. SOCIEDAD VALENCIANA DE NEUMOLOGÍA SOCIEDAD VALENCIANA DE MEDICINA INTENSIVA, CRÍTICA Y UNIDADES CORONARIAS SOCIEDAD VALENCIANA DE MEDICINA FAMILIAR Y COMUNITARIA SOCIEDAD VALENCIANA DE HOSPITALIZACIÓN A DOMICILIO. I.S.B.N: 978-84-17524-13-5; 2019
[30] Radunovic A, Annane D, Rafiq MK, Brassington R, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2017;2018. https://doi.org/10.1002/14651858.CD004427.pub4.
DOI: 10.1002/14651858.CD004427.pub4
[31] Estella Á, Saralegui I, Rubio Sanchiz O, Hernández-Tejedor A, López Camps V, Martín MC, et al. Puesta al día y recomendaciones en la toma de decisiones de limitación de tratamientos de soporte vital. Med Intensiva 2020;44:101–12. https://doi.org/10.1016/j.medin.2019.07.006.
DOI: 10.1016/j.medin.2019.07.006
[32] Zafra MJ, Barrot E, Cabrera C, Del Campo F, Díaz S, Escarabill J, et al. Manual SEPAR de Procedimientos 25: “TERAPIAS RESPIRATORIAS y CUIDADOS DEL PACIENTE NEUROMUSCULAR CON AFECTACIÓN RESPIRATORIA”. ISBN: 978-84-94-0708-3-9; 2012.
[33] Mayaux J, Lambert J, Morélot-Panzini C, Gonzalez-Bermejo J, Delemazure J, Llontop C, et al. Survival of amyotrophic lateral sclerosis patients after admission to the intensive care unit for acute respiratory failure: an observational cohort study. J Crit Care 2019;50:54–8. https://doi.org/10.1016/j.jcrc.2018.11.007.
DOI: 10.1016/j.jcrc.2018.11.007
[34] Patrick Engkasan J, Chan SC. Does non-invasive ventilation compared to invasive ventilation improve short term survival for acute respiratory failure in people with neuromuscular disease and chest wall disorders? A Cochrane Review summary with commentary. Dev Med Child Neurol 2020;62:415–6. https://doi.org/10.1111/dmcn.14501.
DOI: 10.1111/dmcn.14501
[35] López-Padilla D, Corral Blanco M, Ferrer Espinosa S, Romero Peralta S, Sampol J, Terán Tinedo JR, et al. [Intermediate Respiratory Care Units: Questions and Answers]. Open Respir Arch 2022;4:100220. https://doi.org/10.1016/j.opresp.2022.100220.
DOI: 10.1016/j.opresp.2022.100220
[36] Brill A-K. How to avoid interface problems in acute noninvasive ventilation. Breathe 2014;10:230–42. https://doi.org/10.1183/20734735.003414.
DOI: 10.1183/20734735.003414
[37] Quintero OI, Sanchez AI, Chavarro PA, Casas IC, Ospina Tascón GA. Impact of Using a Novel Gastric Feeding Tube Adaptor on Patient’s Comfort and Air Leaks During Non-invasive Mechanical Ventilation. Arch Bronconeumol 2020;56:353–9. https://doi.org/10.1016/j.arbres.2019.10.002.
DOI: 10.1016/j.arbres.2019.10.002
[38] Rodríguez de Rivera FJ. Tratamiento Patogénico. Guía Clínica Para El Trat. Escler. Lateral Amiotrófica, Signo Comunicación Consultores; 2022, p. 45–54.
[39] Institute for Safe Medication Practices. Do not crush list 2020.
[40] Marin B, Arcuti S, Jesus P, Logroscino G, Copetti M, Fontana A, et al. Population-Based Evidence that Survival in Amyotrophic Lateral Sclerosis is Related to Weight Loss at Diagnosis. Neurodegener Dis 2016;16:225–34. https://doi.org/10.1159/000442444.
DOI: 10.1159/000442444
[41] Choi S-J, Yoon SH, Sung J-J, Lee JH. Association Between Fat Depletion and Prognosis of Amyotrophic Lateral Sclerosis: CT-Based Body Composition Analysis. Ann Neurol 2023;94:1116–25. https://doi.org/10.1002/ana.26775.
DOI: 10.1002/ana.26775
[42] Li J-Y, Sun X-H, Cai Z-Y, Shen D-C, Yang X-Z, Liu M-S, et al. Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis. Sci Rep 2022;12:13292. https://doi.org/10.1038/s41598-022-16229-9.
DOI: 10.1038/s41598-022-16229-9
[43] Lee I, Kazamel M, McPherson T, McAdam J, Bamman M, Amara A, et al. Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study. PloS One 2021;16:e0251087. https://doi.org/10.1371/journal.pone.0251087.
DOI: 10.1371/journal.pone.0251087
[44] Kak M, Issa NP, Roos RP, Sweitzer BJ, Gottlieb O, Guralnick A, et al. Gastrostomy tube placement is safe in advanced amyotrophic lateral sclerosis. Neurol Res 2017;39:16–22. https://doi.org/10.1080/01616412.2016.1259028.
DOI: 10.1080/01616412.2016.1259028
[45] Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. Lancet Neurol 2015;14:702–9. https://doi.org/10.1016/S1474-4422(15)00104-0.
DOI: 10.1016/S1474-4422(15)00104-0
[46] Yang B, Shi X. Percutaneous endoscopic gastrostomy versus fluoroscopic gastrostomy in amyotrophic lateral sclerosis (ALS) sufferers with nutritional impairment: A meta-analysis of current studies. Oncotarget 2017;8:102244–53. https://doi.org/10.18632/oncotarget.22288.
DOI: 10.18632/oncotarget.22288
[47] Wills A-M, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Lond Engl 2014;383:2065–72. https://doi.org/10.1016/S0140-6736(14)60222-1.
DOI: 10.1016/S0140-6736(14)60222-1